2017 Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. Group Chronic Malignancies Working Party (CMWP) 1st listed author de Witte T Journal Blood
2017 Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Onida F Journal Br J Haematol.
2017 Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author van Gelder M Journal Clin Lymphoma Myeloma Leuk.
2017 Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT). Group Chronic Malignancies Working Party (CMWP) 1st listed author Schetelig J Journal Br J Haematol.
2017 Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal J Clin Oncol.
2017 High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cook G Journal Haematologica.
2017 Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes. Group Chronic Malignancies Working Party (CMWP) 1st listed author Martino R Journal Bone Marrow Transplant.
2017 Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Schetelig J Journal Bone Marrow Transplant.
2017 Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Scheid C Journal Bone Marrow Transplant.
2016 Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Heidenreich S Journal Biol Blood Marrow Transplant.
2016 Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Sobh M Journal Leukemia
2016 Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal N Engl J Med.